Research Article
The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid
Table 4
Adverse event profile of eicosapentaenoic acid-free fatty acid (EPA-FFA).
| ||||||||||||||||||||||||||||||||||||||||||||||||
Frequency is the absolute number of times given adverse events occurred. HV: healthy volunteers. IBD: inflammatory bowel disease. |